In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Amy Bucher, chief behavioural officer at Lirio, a ...
Distilling that complexity into a handful of trends has been no small task. What follows is not a definitive forecast, but ...
Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...
Months of uncertainty have come to a close. The BIOSECURE Act, now part of the National Defense Authorization Act (NDAA), will put in motion US government-wide restrictions on ‘biotechnology companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback